Expression of Prothrombin Fragment 1+2 in Cancer Tissue as an Indicator of Local Activation of Blood Coagulation
- 1 March 2000
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 97 (5) , 335-342
- https://doi.org/10.1016/s0049-3848(99)00169-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgeryBritish Journal of Haematology, 1993
- Prothrombin Fragment F 1 + 2 Plasma Concentrations in Patients with Gynecologic MalignanciesGynecologic Oncology, 1993
- Changes in Plasma Levels of Prothrombin Fragment F1+2 in Cases of Disseminated Intravascular CoagulationActa Haematologica, 1993
- Coagulation Abnormalities in Malignancy: A ReviewSeminars in Thrombosis and Hemostasis, 1992
- Pathways of Coagulation/Fibrinolysis Activation in MalignancySeminars in Thrombosis and Hemostasis, 1992
- Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lungCancer, 1990
- Fibrin‐enhanced endothelial cell organizationJournal of Cellular Physiology, 1985
- Specificity of a monoclonal antibody for the NH2-terminal region of fibrinMolecular Immunology, 1984
- A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrinMolecular Immunology, 1983
- Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma.Journal of Clinical Investigation, 1977